Clinical Trials Browser

Phase 4 × Completed × ixazomib × Clear all

NCT04217967 2024-08-01

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Phase 4 Completed

Multiple Myeloma